Salicylamide ether compounds of pleuromutilin and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WUHAN INSTITUTE OF TECHNOLOGY
- Publication Date
- 2011-09-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of chemically synthesized medicines, in particular to a pleuromutilin derivative salicylamide ether compound of pleuromutilin and a preparation method thereof. Background technique
[0002] Pleuromutilin was first isolated and initially identified by Kavanagh et al. in 1951. It is a class of broad-spectrum diterpene antibiotics produced by the higher fungi Pleuromyces and Pleuromyces, which can effectively inhibit Gram Positive bacteria, especially staphylococcus and streptococcus are the most obvious, and also have therapeutic effect on mycoplasma infection. Many of its derivatives have stronger antibacterial activity and scope than pleuromutilin, and have a wider antibacterial spectrum. In recent years, with the increasing drug resistance of G+ bacteria, including methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococcus, and vancomycin-resistant enterococcus, the commonly used antibacterial dru...